Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth

1

Psoriasis Therapeutics in Asia-Pacific Markets
to 2021 Advent of Novel Biologics and Expanding
Treatment Pool to Drive Growth

Published By GBI Research
Published May 2015
2
Description


GBI Research, the leading business intelligence
provider, has released its latest research,
Psoriasis Therapeutics in Asia-Pacific Markets to
2021 Advent of Novel Biologics and Expanding
Treatment Pool to Drive Growth, which provides
insights into psoriasis therapeutics in the
Asia-Pacific (APAC) market. For the purposes of
this report, APAC refers to the market in China,
India, Japan, and Australia only. The report
estimates the market size for 2014, along with
forecasts until 2021. It also covers disease
epidemiology, treatment algorithms, treatment use
patterns, in-depth analysis of pipeline
molecules, clinical trial failure rates, and
analysis of recent deals. It is built using data
and information sourced from proprietary
databases, primary and secondary research, and
in-house analysis carried out by GBI Research
team of industry experts. Based on existing
market products, the compounds that are
witnessing breakthrough are highly diverse in
there mode of action. Drug companies can take
this as an opportunity and work on floating
products that can offer advantage in various
geographies.
3
Description


Scope The report analyzes treatment use
patterns, market characterization, the pipeline,
and key licensing and co-development deals for
psoriasis in the APAC markets of China, India,
Japan, and Australia. The report includes - -
In-depth analysis of currently marketed drugs,
including analysis of safety, efficacy, treatment
patterns, and strengths/weaknesses, along with a
heat map comparing them in terms of safety and
efficacy - A comprehensive review of the pipeline
for psoriasis, including individual analysis of a
number of late-stage pipeline drugs likely to
enter the market during the forecast period the
pipeline is further analyzed on the basis of
phase distribution, molecule type, program type,
mechanism of action, and molecular target -
Discussion of the drivers of and barriers to
market growth - In-depth analysis of all
licensing and co-development deals that have
occurred in the psoriasis market since 2006
4
Description

Reasons to buy The report will enhance your
decision-making capability by allowing you to -
- Understand the psoriasis pipeline and the
factors that indicate that it is becoming more
innovative - Analyze detailed profiles for
promising pipeline products and gain insights
into how they are likely to compete in the market
and who their main competitors will be - Follow
the trends in psoriasis clinical trial size and
duration in relation to industry averages -
Assess the potential risk of future developmental
programs for psoriasis therapeutics by mechanism
of action using recorded clinical trial failure
rates - Analyze the potential growth patterns
expected for the psoriasis market over the
forecast period - Identify the countries that are
expected to contribute the most to this growth
and devise a more effectively tailored country
strategy through an understanding of key drivers
and barriers - Accelerate and strengthen your
market position by identifying key companies for
strategic partnerships
5
Table of Contents

• 1 Table of Contents
• 1.1 List of Tables
• 1.2 List of Figures
• 2 Executive Summary
• 2.1 Skin Manifestations
• 3 The Case for Innovation in Asthma
• 3.1 Mental Health Disorders
• .
• 4 Psoriasis Market to 2021 Pipeline Products
• 4.1 Clinical Trials
• 5 Market Forecast to 2021
• 5.1 Asia-Pacific Market Overview  

6
Table of Contents

• 6 Deals and Strategic Consolidations 
• 7 All Pipeline Drugs by Phase
• For inquiry, kindly contact at
  http//www.reportsandintelligence.com/enquire-abou
  t-report/245545
• To check table of contents of the research, Visit
  _at_ http//www.reportsandintelligence.com/psoriasis
  -therapeutics-in-asia-pacific-to-2021-advent-of-no
  vel-biologics-and-expanding-treatment-pool-to-driv
  e-growth-market/table-of-contents

7

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/psoriasis-th
erapeutics-in-asia-pacific-to-2021-advent-of-novel
-biologics-and-expanding-treatment-pool-to-drive-g
rowth-market
Stay With Us
TELEPHONE Direct 1 [phone] Toll Free
1 [phone]E-MAIL sales_at_reportsandintellig
ence.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States